{
  "id": 19347487,
  "title": "STAT+: GLP-1s are given an FDA warning for rare eye condition risk",
  "url": "https://urgent.news/2026/11/10/stat-glp-1s-are-given-an-fda-warning-for-rare-eye-condition-risk",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T14:38:29.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/10/biotech-news-glp-1-given-an-fda-warning-for-rare-eye-condition-risk/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Free Malaysia Today",
        "title": "US FDA requires GLP-1 drugmakers to add warning about potential eye risk",
        "url": "https://urgent.news/2026/11/10/us-fda-requires-glp-1-drugmakers-to-add-warning-about-potential-eye",
        "published": "2026-11-10T05:15:47.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}